Atorvastatin Calcium Tablet
Product Images NDC 68071-3912

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3912 9)

Atorvastatin Calcium 10 mg tablets label from NuCare Pharmaceuticals, Inc. This prescription oral tablet bottle label indicates a quantity of 90 tablets. The label includes the NDC 68071-3912-9, caution to keep out of reach of children, storage temperature instructions, and barcode information. Manufacturer details and product number R1519090 are also visible.*

FDA Label Image

Image (B94c6347 161c 44f2 8937 34c5098bf755 01)

Chemical structure diagram of atorvastatin calcium, depicting the molecular arrangement including aromatic rings, hydroxyl groups, fluorine, and calcium ion complex with water molecules.*

FDA Label Image

Image (B94c6347 161c 44f2 8937 34c5098bf755 02)

A line graph showing cumulative incidence percentage over time in years for two groups: Atorvastatin and Placebo. The x-axis represents time from 0 to 3.5 years, and the y-axis shows cumulative incidence from 0% to 4%. Atorvastatin has a lower cumulative incidence compared to Placebo. There is a hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005 indicated on the graph.*

FDA Label Image

Image (B94c6347 161c 44f2 8937 34c5098bf755 03)

A line chart showing the cumulative hazard percentage over up to five years of follow-up. The graph compares placebo (dashed line) and atorvastatin (solid line) groups, illustrating the time to first primary endpoint during the study period. Hazard ratio and statistical significance are noted in the chart.*

FDA Label Image

Image (B94c6347 161c 44f2 8937 34c5098bf755 04)

A Kaplan-Meier curve graph showing the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time in years, and the y-axis represents the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a 95% confidence interval and a p-value indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.